longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Intuitive Surgical

ISRG

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfileWeekly ReviewWeekly Review
LongbridgeAI

Current ValuationThe current P/E ratio is 44.27, below the reasonable range, cheaper than 96.17% of the time in the past 5 years, and the industry ranks 38/175, the industry Median -0.90.

44.27xP/E
$393.33Stock price
$8.88Earnings per share
44.27xP/E
Stock price$393.33Earnings per share$8.88

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
70.27x
Typical range
58.27x–78.45x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
ABTUSAbbott Laboratories
33.09x5.11%$178.71B
ISRGUSIntuitive Surgical
44.27x17.25%$138.95B
IDXXUSIDEXX Labs
35.37x12.89%$40.31B
DXCMUSDexCom
33.73x19.36%$33.72B
ITGRUSInteger
33.43x5.33%$4.29B
NVSTUSEnvista
39.48x313.05%$3.75B
OMCLUSOmnicell
37.62x2,358.33%$1.47B
VREXUSVarex Imaging
35.26x127.65%$779.32M
MBAIUSMBody AI
36.66x--$18.62M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.